Vitrolife appoints Elin Frostehav CEO

Bitget2026/10/26 09:16

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vitrolife appoints Elin Frostehav president and CEO effective May 1, 2027, or earlier.
Frostehav currently leads Getinge’s Acute Care Therapies business; she previously served as vice president of Critical Care from 2019 to 2022.
Rickard Ericsson, senior vice president of innovation, becomes interim president and CEO November 1, 2026, succeeding Bronwyn Brophy O'Connor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vitrolife AB published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03